These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9742031)

  • 1. HIV-protease inhibitors.
    Di Perri G; Del Bravo P; Concia E
    N Engl J Med; 1998 Sep; 339(11):773-4; author reply 774. PubMed ID: 9742031
    [No Abstract]   [Full Text] [Related]  

  • 2. Ritonavir, triglycerides, and pancreatitis.
    Perry RC; Cushing HE; Deeg MA; Prince MJ
    Clin Infect Dis; 1999 Jan; 28(1):161-2. PubMed ID: 10028103
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute pancreatitis as a complication of ritonavir therapy in a patient with AIDS.
    Mirete G; Masiá M; Gutiérrez F; Mora A; Escolano C; Maestre A
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):810-1. PubMed ID: 9923528
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute pancreatitis caused by tipranavir/ritonavir-induced hypertriglyceridaemia.
    Chapman SJ; Woolley IJ; Visvanathan K; Korman TM
    AIDS; 2007 Feb; 21(4):532-3. PubMed ID: 17301578
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipid disorders in antiretroviral-naive patients treated with lopinavir/ritonavir-based HAART: frequency, characterization and risk factors.
    Montes ML; Pulido F; Barros C; Condes E; Rubio R; Cepeda C; Dronda F; Antela A; Sanz J; Navas E; Miralles P; Berenguer J; Pérez S; Zapata A; González-García JJ; Peña JM; Vázquez JJ; Arribas JR
    J Antimicrob Chemother; 2005 May; 55(5):800-4. PubMed ID: 15761071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 7. Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate.
    Manfredi R; Chiodo F
    J Infect; 2001 Apr; 42(3):181-8. PubMed ID: 11545549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked hypertriglyceridaemia associated with ritonavir therapy.
    Sullivan AK; Feher MD; Nelson MR; Gazzard BG
    AIDS; 1998 Jul; 12(11):1393-4. PubMed ID: 9708422
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acute myocardial infarct in HIV-positive patients in treatment with protease inhibitors].
    Gurgo AM; Massino Ferri F; Iulianella R; Luciani C; Lucifero A; Staropoli P; Rocchi M
    Ital Heart J Suppl; 2001 Nov; 2(11):1236-9. PubMed ID: 11775417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lopinavir/ritonavir- and indinavir-induced thrombocytopenia in a patient with HIV infection.
    Colebunders R; De Schacht C; Vanwolleghem T; Callens S
    Int J Infect Dis; 2004 Sep; 8(5):315-6. PubMed ID: 15325601
    [No Abstract]   [Full Text] [Related]  

  • 11. Hyperlipidemia associated with the use of protease inhibitors.
    Smith JH; Martin GJ; Decker CF
    Clin Infect Dis; 2000 Jul; 31(1):207-8. PubMed ID: 10913432
    [No Abstract]   [Full Text] [Related]  

  • 12. Ritonavir and anemia in women.
    AIDS Patient Care STDS; 2000 Feb; 14(2):102. PubMed ID: 10743525
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.
    Martínez E; Domingo P; Galindo MJ; Milinkovic A; Arroyo JA; Baldovi F; Larrousse M; León A; de Lazzari E; Gatell JM
    Clin Infect Dis; 2004 Apr; 38(7):1017-23. PubMed ID: 15034836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral activity and safety of lopinavir/ritonavir in protease inhibitor-experienced HIV-infected children with severe-moderate immunodeficiency.
    Resino S; Bellón JM; Muñoz-Fernández MA;
    J Antimicrob Chemother; 2006 Mar; 57(3):579-82. PubMed ID: 16446377
    [No Abstract]   [Full Text] [Related]  

  • 15. Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?
    Eriksson U; Opravil M; Amann FW; Schaffner A
    AIDS; 1998 Oct; 12(15):2079-80. PubMed ID: 9814881
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute hepatitis in HIV-infected patients during ritonavir treatment.
    Arribas JR; Ibáñez C; Ruiz-Antoran B; Peña JM; Esteban-Calvo C; Frías J; Vázquez JJ; González-García JJ
    AIDS; 1998 Sep; 12(13):1722-4. PubMed ID: 9764797
    [No Abstract]   [Full Text] [Related]  

  • 17. Ritonavir and renal failure.
    Chugh S; Bird R; Alexander EA
    N Engl J Med; 1997 Jan; 336(2):138. PubMed ID: 8992345
    [No Abstract]   [Full Text] [Related]  

  • 18. Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program.
    Pérez-Elias MJ; Sánchez-Conde M; Soriano V; Mallolas J; Luque I; Rodríguez-Alcántara F;
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):28-32. PubMed ID: 19218000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment: boosted PIs and metabolism--it's not just the ritonavir.
    Moyle GJ
    AIDS Read; 2005 Oct; 15(10):531. PubMed ID: 16265769
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasmapheresis in the treatment of an acute pancreatitis due to protease inhibitor-induced hypertriglyceridemia.
    Routy JP; Smith GH; Blank DW; Gilfix BM
    J Clin Apher; 2001; 16(3):157-9. PubMed ID: 11746545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.